Navigation Links
Dendreon Reports First Quarter 2011 Financial Results
Date:5/2/2011

DATED STATEMENTS OF OPERATIONS(in thousands, except per share amounts)Three Months Ended
March 31,20112010(unaudited)Revenue

$28,061$21Cost of revenue

18,338—Gross profit

9,72321Operating expenses:Research and development

17,60929,414Selling, general and administrative

95,28928,218Total operating expenses

112,89857,632Loss from operations

(103,175)(57,611)Interest income

400278Interest expense

(8,993)(314)(Loss) gain from valuation of warrant liability

—(68,083)Net loss

($111,768)($125,730)Basic and diluted net loss per share

($0.77)($0.96)Shares used in computation of basic anddiluted net loss per share

145,494131,456March 31,December 31,20112010Balance Sheet Data:Cash and cash equivalents

$555,297$132,995Short-term investments

157,094121,796Long-term investments

66,63022,505Trade accounts receivable

16,86412,679Prepaid antigen costs

24,32517,656Inventory

38,87230,928Total  assets

1,130,688603,953Convertible senior notes due 2016

491,424—Convertible senior subordinated notes due 2014

27,68527,685Total stockholders' equity

526,451492,774DENDREON CORPORATIONRECONCILIATION OF GAAP TO NON-GAAP NET LOSS (in thousands, except per share amounts)Three Months Ended
March 31,20112010(unaudited)GAAP net loss

($111,768)($125,730)Non-GAAP adjustments:Depreciation and amortization expense

7,4092,465Stock-based compensation expense

14,6767,070Imputed interest related to the convertible
senior notes due 2016

4,300—Non-GAAP net loss

($85,383)($116,195)Non-GAAP net loss per share- basic and diluted

($0.59)($0.88)Shares used in computation of basic anddiluted net loss per share

145,494131,456The above table provides certain non-GAAP financial measures that include adjustments to GAAP figures. Dendreon believes that these non-GAAP fina
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dendreon to Host Conference Call on May 2, 2011 to Announce First Quarter 2011 Financial Results
2. Dendreon Reports Fourth Quarter and 2010 Year End Financial Results
3. Dendreon Announces Webcast Presentations at Four Upcoming Conferences
4. Dendreon Announces Presentation of PROVENGE Data at the 2011 Genitourinary Cancers Symposium Annual Meeting
5. Dendreon to Host Conference Call on March 1st to Announce Fourth Quarter and Year-End Financial Results
6. Dendreon Announces Pricing of $540 Million Convertible Senior Notes Due 2016
7. Dendreon Announces Plans to Seek Marketing Authorization for PROVENGE in Europe
8. Dendreon to Host Conference Call to Provide Updates on U.S. Commercialization Progress, European Strategy for PROVENGE, and Pipeline Progress
9. Dendreon Announces MEDCAC Panel Reviewed PROVENGE Evidence
10. Dendreon Submits Post-Approval Supplement to the PROVENGE Biologics License Application for New Jersey Manufacturing Facility
11. Dendreon to Host Conference Call on November 3rd to Announce Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... Phenome Networks, a software-as-a-service plant ... availability, beginning May 31st, of its next-generation Phenome One ... solidifies Phenome Networks’ lead in the plant breeding market, ... intuitive breeding workflow based on years of experience with ... design, and more. The new version of Phenome One, ...
(Date:5/22/2015)... MA (PRWEB) May 22, 2015 ... the U.S. Department of Agriculture (USDA), Grain Inspection, ... five year contract to Charm Sciences to monitor ... Quantitative Test (water-based) and ROSA FAST Aflatoxin Quantitative ... Aflatoxin Quantitative Test uses Water Extraction Technology ...
(Date:5/21/2015)... , May 21, 2015 /PRNewswire/ - SQI Diagnostics ... life sciences company that develops and commercializes proprietary technologies ... financial and operational results for the second fiscal quarter ... quarter the Company continued to advance business with our ... Andrew Morris , President and CEO of SQI. "The ...
(Date:5/21/2015)... 21, 2015  Susan Hedstrom, Executive Director of ... organization dedicated to supporting research to advance the ... today that FPWR has received the organization,s largest ... contributed $1 million in support of the ... "Our gift signifies our ...
Breaking Biology Technology:Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 2Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 3USDA-GIPSA (FGIS) Awards 5 Year Contract for Aflatoxin Tests to Charm Sciences 2SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8The Foundation for Prader-Willi Research Receives $1M Contribution in Support of Clinical Initiatives 2
... the completion of a successful prototype, engineers at Oregon State ... the leading problems in energy use around the world today ... produced by cars, factories and power plants. New technology ... low-to-medium grade waste heat that,s now going out the exhaust ...
... June 10, 2011 The neurological system is the ... human brain performs so many amazing tasks on a ... that over 600 brain disorders have currently been identified ... neurosurgeons. The American Academy of Neurology, The Congress of ...
... 2011 PharmaNet Development Group, Inc. (the "Company" or "PharmaNet") ... and consent solicitation (the "Offer") for any and all of ... "Notes"), it has elected to extend the consent payment deadline ... on June 10, 2011, unless extended or earlier terminated (the ...
Cached Biology Technology:Prototype demonstrates success of advanced new energy technology 2Prototype demonstrates success of advanced new energy technology 3Mediaplanet Launches Campaign for Awareness of Neurological Issues 2PharmaNet Extends Consent Payment Deadline for Notes Tendered in Its Tender Offer and Consent Solicitation 2PharmaNet Extends Consent Payment Deadline for Notes Tendered in Its Tender Offer and Consent Solicitation 3PharmaNet Extends Consent Payment Deadline for Notes Tendered in Its Tender Offer and Consent Solicitation 4
(Date:5/11/2015)... N.Y. , May 11, 2015 Curemark ... announced the start of a new Phase III double ... of its novel formulation, CM-AT, on all children ages ... of its FDA Phase III double blinded clinical trial ... had low levels of the digestive enzyme chymotrypsin. This ...
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
(Date:4/27/2015)... Profile Solutions, Inc. (OTC: PSIQ), a leading ... pleased to announce that Dr Gerry Bedore ... of its scientific advisory board. ... leader in technology-enhanced learning models. He was a co-founder ... studies and books focused on online student success and ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... ARBOR, Mich. An early laboratory success is taking ... gland transplants that could one day prevent a currently ... The scientists were able to induce embryonic stem ... hormone essential to maintaining bone density. The laboratory results ...
... ANN ARBOR, Mich.---Brain implants that can more clearly record ... at the University of Michigan. The findings could eventually ... as Parkinson,s disease and paralysis. Neural electrodes must ... When the electrodes are implanted, the brain first reacts ...
... calling on Congress to support the Consistency, Accuracy, Responsibility ... (CARE bill), which would ensure that states set minimum ... bill (H.R. 3652) was introduced Sept. 28 in the ... "The introduction of the CARE bill ...
Cached Biology News:Stem cell success points to way to regenerate parathyroid glands 2A step toward better brain implants using conducting polymer nanotubes 2A step toward better brain implants using conducting polymer nanotubes 3SNM urges Congress to support CARE bill 2